Objective: Limited data exist comparing perioperative morbidity and mortality after open and endovascular abdominal aortic aneurysm (AAA) repair (EVAR) among regions of the United States. This study evaluated the regional variation in mortality and perioperative outcomes after repair of AAAs.
Abdominal aortic aneurysms (AAAs) are one of the most common conditions treated by vascular surgeons in the United States, with w40,000 procedures performed annually among Medicare beneficiaries alone. 1 In its efforts to guide clinician practice, the Society for Vascular Surgery (SVS) developed clinical practice guidelines and quality initiatives aimed at improving patient care. 2 The Centers for Medicare and Medicaid
Services (CMS) also established the Physician Quality
Reporting System aimed at encouraging physician engagement in active outcome reporting through the provision of financial incentives. 3 The practice measures developed by the SVS and CMS have identified specific outcomes as benchmarks for quality care after open AAA repair and endovascular AAA repair (EVAR). SVS guidelines include a recommendation that AAA repairs be performed at centers with in-hospital mortality rates of <3% for EVAR and <5% for open repair of elective infrarenal AAAs. Physician Quality Reporting System measures also include the rate of in-hospital mortality after repair of small to moderate aneurysms (<5.5 cm for women, <6 cm for men) and the proportion of patients discharged to home after elective repair by postoperative day 2 for EVAR and day 7 for open repair. Regional variation in surgical practice has been increasingly evaluated in recent years, with findings suggesting that the chance a patient will undergo surgery is related to where he or she resides as much as the indication for surgery. 5 To better understand these findings, researchers attempted to categorize variation as acceptable, of unknown significance, or unwarranted. Acceptable variation includes differences in patient demographics as well as variation in management technique where best practice is not defined; however, research has found that acceptable variation explains only a small portion of the variation seen in surgical practice today. 5 Unwarranted variation is more troubling and represents variation that is not the result of patient needs or preferences but rather may represent variation in practice and outcomes where clear evidence and clinical benchmarks exist. 6 Despite the growing body of literature on regional variation, the extent of variation in vascular surgery remains poorly defined, particularly in the area of aortic disease. Furthermore, quantification of variation is necessary to identify optimal targets for quality improvement efforts aimed at improving care and reducing variation. Despite the current wide distribution and publication of clinical practice guidelines, significant regional variation has been identified in the use of EVAR for intact (66%-88%) and ruptured (40%-80%) AAA. 7 However, regional variation in mortality and length of stay, as well as other previously defined process measures, remains unknown. Given this gap in knowledge and the importance of identifying targets for quality improvement, this study evaluated the regional variation and hospital variation within each region in morbidity and mortality after AAA repair in the United States.
METHODS
The Vascular Quality Initiative (VQI) was used to identify all patients undergoing open or EVAR of infrarenal AAAs between 2009 and 2014. AAA extent was defined according to the location of the proximal clamp. Repairs of intact and ruptured aneurysms were evaluated separately. All regions with >100 reported open AAA repairs were included for analysis, and regions with <100 cases were combined into a single region in an effort to decrease the effect of low-volume regions. At the time of this study, the VQI consisted of 16 regional quality groups distributed across the United States, which were condensed into 14 regions for this analysis. All regions included university and community hospitals. For this study, the combined group was not an outlier (highest or lowest region) for any of the outcomes measured. The Beth Israel Deaconess Medical Center Institutional Review Board approved this study and waived informed consent because deidentified data were used.
Variables. Perioperative outcome variables and longterm mortality data were collected for all patients. Small aneurysms were defined as <5 cm for women and <5.5 cm for men according to SVS guidelines. 2 Per CMS benchmarks, small to moderate aneurysms were defined as <5.5 cm for women and < 6 cm for men. 4 Because of differing cutoffs between the SVS guidelines and CMS benchmarks, mortality was analyzed for both small and small to moderate aneurysms. The VQI uses the Social Security Death Index to improve the accuracy of mortality reporting. Prolonged length of stay was defined as >7 days for open surgery and >2 days for EVAR or discharge to a nonhome location after repair of an intact aneurysm in accordance with CMS measures. 4 After open or endovascular repair of a ruptured AAA, length of stay >7 days was evaluated.
For intact aneurysms, we evaluated transfusion >3 units after open AAA repair and any transfusion after EVAR. After rupture, we evaluated transfusion >3 units for all patients.
Change in renal function was defined by VQI as an increase of 0.5 mg/dL in creatinine or new dialysis. Respiratory complications were defined as pneumonia or reintubation. Myocardial infarction was defined by the VQI as changes in troponin levels, electrocardiogram, and clinical documentation. All outcomes analyzed had <3% missing data, with most of the outcomes >99% complete.
Statistical analysis. Statistical analysis was completed using SPSS 21.0 software (IBM Corp, Armonk, NY), and the Figures were produced using GraphPad Prism 6.0 software (GraphPad Inc, La Jolla, Calif). Fisher exact and c 2 tests were used for binary variables. Forest plots were used to represent the range in frequency of outcome occurrence for each variable of interest. Regions were identified on forest plots using a symbol for each region, and the median for the full VQI was represented with a single vertical line. Pearson correlation testing was used to evaluate the relationship between prolonged length of stay and complications of EVAR and open repair. Risk-adjusted perioperative mortality was calculated using the previously published risk-prediction model for perioperative mortality. 8 An observed-to-expected ratio for mortality was standardized to the overall perioperative mortality in the VQI for the same population. Statistical significance was defined as P < .05.
RESULTS
We Repair of intact aneurysms. After open repair, there was no significant variation across VQI regions in in-hospital, 30-day, or 1-year mortality (Fig 1) . However in-hospital mortality exceeded the SVS benchmark of 5% for two regions (range, 0%-7%). A subgroup analysis showed 11 of 23 hospitals (48%) in those regions exceeded the 5% in-hospital mortality benchmark. Among open repairs for intact aneurysms, 30-day mortality varied from 0% to 8% (P ¼ .38) and 1-year mortality from 0% to 11% (P ¼ .29). When only those regions with the highest and lowest mortality rates were compared, 30-day (P ¼ .03) and 1-year mortality (P < .05) were both significant. Among small aneurysms (<5 cm for women, <5.5 cm for men) in-hospital mortality varied from 0% to 7% (P ¼ .69), 30-day mortality varied from 0% to 6% (P ¼ .73), and 1-year mortality varied from 0% to 10% (P ¼ .48). For small to moderate aneurysms (<5.5 cm for women and <6 cm for men), in-hospital mortality varied from 0% to 6% (P ¼ .23), 30-day mortality ranged from 0% to 4% (P ¼ .58), and 1-year mortality varied from 0% to 7% (P ¼ .53). Risk-adjusted perioperative (in-hospital or 30-day) mortality varied from 0% to 9% after open repair, similar to the unadjusted analysis (Fig 2) .
Rates of in-hospital and 30-day mortality after EVAR varied from 0% to 1% (P ¼ .75) and 0% to 2% (P ¼ .12) across VQI regions, respectively. Only 1-year mortality varied significantly after EVAR (1%-6%; P < .01). No difference was found for small aneurysms (<5 cm for women, <5.5 cm for men) in in-hospital mortality (0%-1%; P ¼ .36), 30-day mortality (0%-1%; P ¼ .41), or 1-year mortality (1%-4%; P ¼ .09). Among small to moderate aneurysms (<5.5 cm for women, <6 cm for men) there was no variation in in-hospital (0%-1%; P ¼ .49) or 30-day (0%-1%; P ¼ .69) mortality; however, 1-year mortality (1%-5%; P ¼ .01) varied significantly (Fig 1) . Riskadjusted perioperative (in-hospital or 30-day) mortality had minimal variation after EVAR (0%-1%) and was similar to the unadjusted analysis (Fig 2) .
Despite the limited variation in mortality, wide regional variation in perioperative outcomes was seen after repair of intact aneurysms. Significant variation was found in postoperative myocardial infarction (open: 0%-13%; P < .01; EVAR: 0%-3% P < .01), transfusion (open: 10%-35%; P < .01; EVAR: 7%-18%; P < .01), and the use of vasopressors (open: 19%-37%; P < .01; EVAR: 3%-7% P < .01) among both open and EVAR (Figs 3 and 4) . Extubation outside of the operating room varied significantly for both open repair (24%-75%; P < .01) and EVAR (3%-23%; P < .01), with the incidence of subsequent respiratory complications variable but not significant after open repair (6%-20%; P ¼.20). Prolonged length of stay also showed wide regional variation (Fig 5) . After open repair, length of stay >7 days varied from 32% to 53% (P ¼ .54). After EVAR, length of stay >2 days varied from 16% to 43% (P < .01). A correlation was seen between regions with prolonged length of stay for open cases and prolonged length of stay for endovascular cases (R ¼ 0.4, P ¼ .11; Fig 6) . A moderate correlation was noted between prolonged length of stay and any complication after open repair (R ¼ 0.5, P ¼ .05) and EVAR (R ¼ 0.6, P < .01). After EVAR, endoleak at the conclusion of the operation varied significantly among regions (15%-38%; P < .01), as did the frequency of reoperation (1%-4%; P ¼ .01). After open repair, deterioration of renal function also varied across regions (6%-18%; P ¼ .04; Figs 3 and 4) .
Repair after rupture. In-hospital mortality (open: 14%-63%; P ¼ .03; EVAR: 3%-32%; P ¼ .03) and 30-day mortality (open: 14%-63%; P ¼ .046; EVAR: 3%-32%; P ¼ .01) varied significantly across regional groups after repair of ruptured AAAs. The 1-year mortality varied from 14% to 64% after open repair (P ¼ .07) and from 6% to 51% after EVAR (P < .01; Fig 7) .
Perioperative outcomes also varied widely after the repair of ruptured AAA. Transfusion >3 units ranged from 33% to 87% after EVAR (P < .01) and from 47% to 93% after open repair (P < .01). Major postoperative complications, including bowel ischemia (3%-53%; P < .01) and deterioration of renal function (22%-63%; P ¼.02), varied widely among regions after open repair (Fig 8) .
DISCUSSION
Our results found that although mortality rates after repair of intact AAAs do not vary significantly across regions of the United States, the variation is clinically relevant after open repair and the SVS benchmarks are not universally met. Mortality after repair of ruptured AAA and perioperative complications for both intact and ruptured aneurysms are also widely variable across regional groups in VQI.
In-hospital mortality after repair of intact aneurysms varied from 1% to 7% for open repair, with two regions exceeding the SVS guideline of <5%. We previously showed that significant regional variation exists in demographics and comorbidities among patients treated for AAA, which may suggest that the variation in mortality is the result of patient characteristics. 7 However, we elected to include unadjusted rates to allow comparison with the current SVS guidelines, which also do not use risk adjustment. In addition, mortality rates remained widely variable after open AAA repair after risk adjustment, with a variation similar to unadjusted rates. Furthermore, those regions exceeding SVS guidelines of 5% on the unadjusted analysis remained outliers that exceeded 5% mortality rates with adjustment, and a 5% mortality rate was exceeded even for small aneurysms. The high expected mortality identified from patient comorbidities for several regions as well as high mortality after repair of small aneurysms likely identifies a problem with patient selection that may be improved through the use of validated risk calculators in preoperative planning. 8, 9 All regions met the clinical benchmark mortality rate of <3% after EVAR, a benchmark that persisted without wide variation after adjustment for patient Given previous reports suggesting a large proportion of perioperative mortality occurs after discharge, we also evaluated 30-day mortality. 10 All regions were successful in achieving 30-day mortality rates of <2% for EVAR; however, 30-day mortality ranged from 0% to 8% after open repair. 2 Additional efforts are necessary to achieve more universally low mortality rates after open repair of AAA. Furthermore, given that all regions currently achieve mortality rates of <2% after EVAR, an update of SVS guidelines to reflect current practice and recommend EVAR be completed in hospitals with <2% mortality may be reasonable. After rupture, few clinical benchmarks exist. Variation was significant for mortality, bowel ischemia, vasopressor use, renal dysfunction, and length of stay across VQI regions. Because patients have a wide range of hemodynamic conditions and the timing of presentation is beyond the surgeon's control, achieving universally acceptable outcomes after ruptured AAA repair is difficult. However, opportunity exists to standardize care and achieve improved quality. 11 The incorporation of standard protocols using an endovascular-first approach for the treatment of ruptured AAA in patients with suitable anatomy has achieved some success in improving mortality among patients with ruptured AAAs.
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Moore et al 11 found reductions in overall mortality from 39% to 17% after implementation. These data were further supported in similar protocols created at the University of Washington, which achieved success in reducing mortality from 58% to 35% despite worse baseline renal function in the group repaired after implementation. 12 Because several studies have found this method to be successful in reducing overall mortality, SVS now recommends EVAR for the treatment of ruptured AAA in patients with suitable anatomy. 2 However, despite these recommendations, previous work has found the use of EVAR to treat ruptured AAA in the VQI varies widely, from 40% to 80%. 7 Hospital length of stay is also variable after AAA repair. CMS is currently tracking the proportion of patients discharged by day 2 for elective EVAR and day 7 for elective open repair. In the VQI, 30% of patients had a prolonged length of stay after repair (open: 32%-53%, EVAR: 16%-43%). Prior analysis demonstrated the median length of stay among Medicare patients is 2 days after elective EVAR and 7 days after elective open surgery. 17 Given that prolonged length of stay correlates with complications or a lack of efficient postoperative care, it provides an opportunity for continued quality improvement. Improving the rates of discharge by day 2 and day 7 and increasing the use of EVAR for ruptured AAA are important measures that are already being used by CMS and SVS, respectively. However, this study identifies other measures deserving increased emphasis and research, including rates of transfusion, vasopressor use, postoperative myocardial infarction, timing of extubation, and renal dysfunction.
Similar to this study, previous research has noted wide variation in transfusion practices among cardiovascular and general surgery patients, with noted associations found between transfusion and increased morbidity and mortality. [18] [19] [20] [21] [22] [23] These data were further supported by studies from the trauma literature, which suggested that increased transfusion is harmful to patients even when hypovolemia is present. 24, 25 Moreover, in a randomized trial of patients requiring transfusion for gastrointestinal bleeding, a restrictive transfusion strategy (hemoglobin <7 g/dL) achieved improved outcomes compared with liberal transfusion (hemoglobin <9 g/dL), leading to major shifts in practice. 26 The most recent guidelines from SVS begin to address the challenges of transfusion by recommending intraoperative transfusion for a hematocrit of <30% with ongoing blood loss and transfusion for a preoperative hematocrit of <28%. However, the quality of this evidence was weak, and the optimal transfusion goal for vascular patients is currently unknown. Although the use of liberal transfusion has not been studied in a randomized fashion among patients with AAA repair, there is sufficient evidence associating transfusion with adverse outcomes that novel research on liberal and restrictive transfusion (and their effect on cardiac and respiratory complications) is warranted. This study also identified wide variation in the frequency of extubation outside of the operating room and the respiratory complications associated with prolonged intubation. Data from cardiac surgery, including randomized clinical trials, associate early extubation with improved length of stay and cost savings, and current guidelines recommend anesthetic management directed toward early postoperative extubation after uncomplicated coronary artery bypass grafting. 27 Given these data, quality improvement projects identifying optimal extubation timing to minimize the subsequent respiratory complications are also warranted.
This study found wide variation in the frequency of postoperative myocardial infarction. Despite an SVS guideline for noninvasive stress testing for patients with known cardiac disease, our previous work found significant variation in the preoperative evaluation of patients with known cardiac disease, including variation in the use of preoperative stress testing (31%-73%) among patients undergoing elective repair. 2, 7 Clinical process benchmarks have become increasingly accepted in the past decade and have been shown to be an effective component of quality improvement. In a systemic review of all studies evaluating the effectiveness of the Surgical Care Improvement Project (SCIP), researchers found an 18% decrease in the odds of that a surgical site infection would develop after implementation of the SCIP process measures and significant progress toward the SCIP task force goal of 25% reduction in surgical site infections. 28 Clinician feedback through the use of national registries has also been effective in improving clinical outcomes. Among patients undergoing cardiac surgery, studies have found that routine feedback on local performance compared with peers, in an effort to improve quality of care, was associated with increased self-assessment and subsequent improvements in mortality. 29 Similarly, research found increased participation in the VQI led to improved perioperative medical management, which is associated with improved survival. 30 Despite the benefits of the increased emphasis on clinical benchmarks, drawbacks associated with heightened awareness of these measures should also be noted. Recently, long-expressed concerns over patient selection and risk aversion were verified in a study that demonstrated that outcome data influenced physicians' decisions to operate on patients at the highest risk even if the procedure might be beneficial. 31 Furthermore, Joynt et al 32 found that percutaneous coronary intervention rates for myocardial infarction declined after the initiation of a reporting system in Massachusetts and were significantly lower in states with mandatory reporting compared with similar states in the same region. This study has several limitations that should be addressed. First, this study is bound by all limitations of large clinical databases, including coding errors, variable definitions that may differ from other registries, and missing data. However, the 1-year mortality data are reliable because the Social Security Death Index was used.
Referral patterns may also affect outcome, but this is not captured in the VQI. Nonetheless, the variation did not change after adjustment for those factors found to be predictive of mortality. An additional limitation of this study is that the number and size of hospitals in each region may not be uniform, and smaller regions may be disproportionately affected by a few large centers. However, subgroup analysis revealed 50% of hospitals exceeded 5% in-hospital mortality in the two regions that did not meet SVS guidelines, suggesting these findings were not from one or two hospitals alone.
CONCLUSIONS
Despite success in achieving acceptable mortality rates after EVAR, two regions do not meet SVS criteria for acceptable mortality after open repair of AAA. In addition, mortality after repair of ruptured AAA and perioperative outcomes for intact and ruptured AAAs are widely variable. Future quality improvement programs should focus on reducing complications, reducing hospital length of stay, increasing the use of EVAR for ruptured AAA, increasing extubation in the operating room, and improving mortality. Further research is warranted to identify optimal transfusion goals and extubation time to optimize patient outcomes.
